➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Merck
McKesson
McKinsey
Dow

Last Updated: July 28, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,822,438


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,822,438
Title:Methods and compositions for treating cancer
Abstract: Methods and compositions for treating cancer are described herein. More particularly, the methods for treating cancer comprise administering a 17.alpha.-hydroxylase/C.sub.17,20-lyase inhibitor, such as abiraterone acetate (i.e., 3.beta.-acetoxy-17-(3-pyridyl)androsta-5,16-diene), in combination with at least one additional therapeutic agent such as an anti-cancer agent or a steroid. Furthermore, disclosed are compositions comprising a 17.alpha.-hydroxylase/C.sub.17,20-lyase inhibitor, and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid.
Inventor(s): Auerbach; Alan H. (Hermosa Beach, CA), Belldegrum; Arie S. (Los Angeles, CA)
Assignee: Janssen Oncology, Inc. (Los Angeles, CA)
Application Number:13/034,340
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,822,438
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 8,822,438

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,822,438

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2007287098 ⤷  Free Forever Trial
Australia 2015221447 ⤷  Free Forever Trial
Australia 2017201764 ⤷  Free Forever Trial
Australia 2018271331 ⤷  Free Forever Trial
Canada 2661422 ⤷  Free Forever Trial
China 101528308 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Johnson and Johnson
McKinsey
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.